One day we hope to be able to say — well, here’s a disease, and then click a button and out pops the design for a drug to ...

How the application of artificial intelligence, broader use of real-world evidence, decentralized clinical trials, master protocols, and risk-based quality monitoring, together with strong ethical ...

The pivotal trial for Neurogene's Rett syndrome gene therapy makes use of baseline controls and a rigorous endpoint that ...

So, what were the major themes to come out of BIO Boston 2025? Who’s getting excited about what? And – besides the obvious ...

Nuravax Inc., a clinical-stage biopharmaceutical company developing active immunotherapies for neurodegenerative diseases, announced today that two oral presentations—the Phase 1 clinical results and ...

The partners will use UNP's AI-based macrocycle discovery platform to develop synthetic peptide therapeutics for multiple disease targets.

Explore innovative clinical trial design with digital twins, enhancing predictions while reducing costs and efforts in ...

The COVID pandemic illustrated how urgently we need antiviral medications capable of treating coronavirus infections.

Former Abbott executive who led the US launch and global expansion of Humira® adds three decades of commercial and clinical leadership expertise ...

Traditional medical tests often require clinical samples to be sent off-site for analysis in a time-intensive and expensive ...

Scientists from Rutgers University and Brookhaven National Laboratory collaborated on this ongoing research and published a ...